missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Angiopoietin 2 Polyclonal Antibody

Descripción
This antibody is specific for mouse Angiopoietin-2 (mAng-2). Partial cross-reactivity is observed with human Angiopoietin-1. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
ANG-2 binds to the endothelial cell specific receptor Tie-2, but, in contrast to ANG-1, does not induce tyrosine phosphorylation. Consequently, ANG-2 modulates ANG-1 activation of Tie-2 and, depending on the physiological and biochemical environment, can act either as an agonist or antagonist of Tie-2 induced angiogenesis. The signaling interactions of ANG-1, ANG-2 and Tie-2, along with less characterized ANG-3 and ANG-4, are required for embryonic and adult angiogenesis. Physiologically, ANG-1 and ANG-2 are associated with sprouting, tube formation, and structural integrity of newly formed blood vessels. Mature human ANG-2 is a secreted protein containing 480 amino acid residues. ANG-2 is composed of an alpha-helix-rich coiled coil N-terminal domain and fibrinogen-like C-terminal domain. ANG-2 exists predominantly in the form of a disulfide-linked dimer.
Especificaciones
Especificaciones
| Antígeno | Angiopoietin 2 |
| Aplicaciones | Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot |
| Clasificación | Polyclonal |
| Concentración | 80 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 0.1% sodium azide; pH 7.2 |
| génica | ANGPT2 |
| N.º de referencia del gen | O15123, O35608 |
| Alias de gen | AGPT2; Ang2; Ang-2; angiopoietin 2; angiopoietin-2; angiopoietin-2a; angiopoietin-2B; ANGPT2; endothelial growth factor; Tie2-ligand |
| Símbolos de los genes | ANGPT2 |
| Mostrar más |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?